1h Free Analyst Time
The publisher has been monitoring the aptamers market and it is poised to grow by $1.31 bn during 2022-2026, progressing at a CAGR of 27.70% during the forecast period. The report on the aptamers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of cancer boosts demand for novel diagnostics and rising number of clinical trials to develop aptamer-based therapeutics.
The aptamers market analysis includes the application segment and geographic landscape.
The aptamers market is segmented as below:
By Application
- Therapeutics development
- Research and development
- Diagnostic
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the rising awareness of the advantages of aptamers over antibodies as one of the prime reasons driving the aptamers market growth during the next few years.
The report on aptamers market covers the following areas:
- Aptamers market sizing
- Aptamers market forecast
- Aptamers market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading aptamers market vendors that include Aptagen LLC, Aptamer Group Ltd., Aptamer Sciences Inc, APTATARGETS SL, Base Pair Biotechnologies Inc., Kaneka Corp., Maravai LifeSciences Holdings Inc., NeoVentures Biotechnology Inc, SomaLogic Inc, and Vivonics Inc. Also, the aptamers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2021
- Market outlook: Forecast for 2021 - 2026
Five Forces Analysis
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Application
- Market segments
- Comparison by Application
- Therapeutics development - Market size and forecast 2021-2026
- Research and development - Market size and forecast 2021-2026
- Diagnostic - Market size and forecast 2021-2026
- Others - Market size and forecast 2021-2026
- Market opportunity by Application
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2021-2026
- Europe - Market size and forecast 2021-2026
- Asia - Market size and forecast 2021-2026
- ROW - Market size and forecast 2021-2026
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Aptagen LLC
- Aptamer Group Ltd.
- Aptamer Sciences Inc
- APTATARGETS SL
- Base Pair Biotechnologies Inc.
- Kaneka Corp.
- Maravai LifeSciences Holdings Inc.
- NeoVentures Biotechnology Inc
- SomaLogic Inc
- Vivonics Inc
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2021 - 2026 ($ million)
- Global market: Year-over-year growth 2021 - 2026 (%)
- Five forces analysis 2021 & 2026
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2021
- Application - Market share 2021-2026 (%)
- Comparison by Application
- Therapeutics development - Market size and forecast 2021-2026 ($ million)
- Therapeutics development - Year-over-year growth 2021-2026 (%)
- Research and development - Market size and forecast 2021-2026 ($ million)
- Research and development - Year-over-year growth 2021-2026 (%)
- Diagnostic - Market size and forecast 2021-2026 ($ million)
- Diagnostic - Year-over-year growth 2021-2026 (%)
- Others - Market size and forecast 2021-2026 ($ million)
- Others - Year-over-year growth 2021-2026 (%)
- Market opportunity by Application
- Customer landscape
- Market share By Geographical Landscape 2021-2026 (%)
- Geographic comparison
- North America - Market size and forecast 2021-2026 ($ million)
- North America - Year-over-year growth 2021-2026 (%)
- Europe - Market size and forecast 2021-2026 ($ million)
- Europe - Year-over-year growth 2021-2026 (%)
- Asia - Market size and forecast 2021-2026 ($ million)
- Asia - Year-over-year growth 2021-2026 (%)
- ROW - Market size and forecast 2021-2026 ($ million)
- ROW - Year-over-year growth 2021-2026 (%)
- Key leading countries
- Market opportunity By Geographical Landscape ($ million)
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- Aptagen LLC - Overview
- Aptagen LLC - Product and service
- Aptagen LLC - Key offerings
- Aptagen LLC - Key customers
- Aptagen LLC - Segment focus
- Aptamer Group Ltd. - Overview
- Aptamer Group Ltd. - Product and service
- Aptamer Group Ltd. - Key offerings
- Aptamer Group Ltd. - Key customers
- Aptamer Group Ltd. - Segment focus
- Aptamer Sciences Inc - Overview
- Aptamer Sciences Inc - Product and service
- Aptamer Sciences Inc - Key offerings
- Aptamer Sciences Inc - Key customers
- Aptamer Sciences Inc - Segment focus
- APTATARGETS SL - Overview
- APTATARGETS SL - Product and service
- APTATARGETS SL - Key offerings
- APTATARGETS SL - Key customers
- APTATARGETS SL - Segment focus
- Base Pair Biotechnologies Inc. - Overview
- Base Pair Biotechnologies Inc. - Product and service
- Base Pair Biotechnologies Inc. - Key offerings
- Base Pair Biotechnologies Inc. - Key customers
- Base Pair Biotechnologies Inc. - Segment focus
- Kaneka Corp. - Overview
- Kaneka Corp. - Business segments
- Kaneka Corp. - Key offerings
- Kaneka Corp. - Key customers
- Kaneka Corp. - Segment focus
- Maravai LifeSciences Holdings Inc. - Overview
- Maravai LifeSciences Holdings Inc. - Business segments
- Maravai LifeSciences Holdings Inc. - Key offerings
- Maravai LifeSciences Holdings Inc. - Key customers
- Maravai LifeSciences Holdings Inc. - Segment focus
- NeoVentures Biotechnology Inc - Overview
- NeoVentures Biotechnology Inc - Product and service
- NeoVentures Biotechnology Inc - Key offerings
- NeoVentures Biotechnology Inc - Key customers
- NeoVentures Biotechnology Inc - Segment focus
- SomaLogic Inc - Overview
- SomaLogic Inc - Product and service
- SomaLogic Inc - Key offerings
- SomaLogic Inc - Key customers
- SomaLogic Inc - Segment focus
- Vivonics Inc - Overview
- Vivonics Inc - Product and service
- Vivonics Inc - Key offerings
- Vivonics Inc - Key customers
- Vivonics Inc - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global aptamers market: Aptagen LLC, Aptamer Group Ltd., Aptamer Sciences Inc, APTATARGETS SL, Base Pair Biotechnologies Inc., Kaneka Corp., Maravai LifeSciences Holdings Inc., NeoVentures Biotechnology Inc, SomaLogic Inc, and Vivonics Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is rising awareness of the advantages of aptamers over antibodies.`
According to the report, one of the major drivers for this market is the increasing incidence of cancer boosts demand for novel diagnostics.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aptagen LLC
- Aptamer Group Ltd.
- Aptamer Sciences Inc
- APTATARGETS SL
- Base Pair Biotechnologies Inc.
- Kaneka Corp.
- Maravai LifeSciences Holdings Inc.
- NeoVentures Biotechnology Inc
- SomaLogic Inc
- Vivonics Inc
